Abstract
The aim of this study was to investigate the correlation between enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on contrast-enhanced ultrasound (CEUS) and pathological findings. The CEUS enhancement patterns of 40 pathologically proven ICC lesions were retrospectively analysed. Pathologically, the degree of tumour cell and fibrosis distribution in the lesion was semi-quantitatively evaluated. Four enhancement patterns were observed in the arterial phase for 32 mass-forming ICCs: peripheral rim-like hyperenhancement (n = 19); heterogeneous hyperenhancement (n = 6); homogeneous hyperenhancement (n = 3); and heterogeneous hypo-enhancement (n = 4). Among the four enhancement patterns, the differences in tumour cell distribution were statistically significant (p < 0.05). The hyperenhancing area on CEUS corresponded to more tumour cells for mass-forming ICCs. Heterogeneous hyperenhancement (n = 2) and heterogeneous hypo-enhancement (n = 2) were observed in the arterial phase for four periductal-infiltrating ICCs. In this subtype, fibrosis was more commonly found in the lesions. Heterogeneous hyperenhancement (n = 1) and homogeneous hyperenhancement (n = 3) were observed in the arterial phase for four intraductal-growing ICCs. This subtype tended to have abundant tumour cells. The CEUS findings of ICC relate to the degree of carcinoma cell proliferation at pathological examination. Hyperenhancing areas in the tumour always indicated increased density of cancer cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341:1368–1378
Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314
Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806–813
Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353–1357
Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A et al (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut 48:816–820
Liver Cancer Study Group of Japan (1989) The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 19:98–129
Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. Am J Roentgenol 181:819–827
Lim JH, Park CK (2004) Pathology of cholangiocarcinoma. Abdom Imaging 29:540–547
Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F et al (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 29:28–44
Chen LD, Xu HX, Xie XY, Lu MD, Xu ZF, Liu GJ et al (2008) Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 81:881–889
Asayama Y, Yoshimitsu K, Irie H, Tajima T, Nishie A, Hirakawa M et al (2006) Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238:150–155
Lacomis JM, Baron RL, Oliver JH, Nalesnik MA, Federle MP (1997) Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203:98–104
Yoshida Y, Imai Y, Murakami T, Nishikawa M, Kurokawa M, Yonezawa T et al (1999) Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 24:66–68
Vilana R, Forner A, Bianchi L, Garcı′a-Criado A, Rimola J, de Lope CR et al (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51:2020–2029
Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL et al (2006) Characterization of focal liver lesions using contrast enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 34:261–272
Xu HX, Lu MD, Liu GJ, Xie XY, Xu ZF, Zheng YL et al (2006) Imaging of peripheral cholangiocarcinoma with low mechanical index contrast enhanced sonography and SonoVue: initial experience. J Ultrasound Med 25:23–33
Chen LD, Xu HX, Xie XY, Xie XH, Xu ZF, Liu GJ et al (2010) Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 20:743–753
Okamura N, Yoshida M, Shibuya A, Sugiura H, Okayasu I, Ohbu M (2005) Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int 55:724–731
Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H et al (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. Am J Roentgenol 176:1499–1507
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
Conflict of interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article has been retracted upon request of the authors as it contains similarities with paragraphs of a previously published article: Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination. H.-X. Xu et al; British Journal of Radiology 2012; 85:1029-1037.
About this article
Cite this article
Loria, F., Loria, G., Basile, S. et al. RETRACTED ARTICLE: Contrast-enhanced ultrasound appearances of enhancement patterns of intrahepatic cholangiocarcinoma: correlation with pathological findings. Updates Surg 66, 135–143 (2014). https://doi.org/10.1007/s13304-014-0251-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-014-0251-6